June 10, 2006
HDMA supports FDA for Prescription Drug Marketing Act
The Healthcare Distribution Management Association (HDMA) backs the FDA’s decision to lift the stay on the Prescription Drug Marketing Act (PDMA).
FDA will be able to ensure patient safety, prescription drug integrity and supply chain security by enforcing the final rule on December 1, 2006.
John Gray, president and CEO at HDMA stated:
We have zero tolerance for criminals who counterfeit patient medicines, and we commend the FDA for moving forward with implementation of the PDMA Final Rule. It is very important step to introduce drug-sell tracking. Therefore, HDMA will work with the FDA.
He further commented:
We commend the FDA for proactively holding workshops to gather critical information from across the healthcare industry to make this important decision. Additionally we support FDA's focus on prioritizing pedigree enforcement efforts and its recommendation for continued industry leadership on technology advancements.
Via prnewswire
--
Did you enjoy this post?
« FDA to track sale of counterfeit drugs | Main | TAGSYS designs RFID Reader for Libraries »
